Showing results (11-20 of 1,919) with videos related to

Sort By:
Pageof 192
Expert Opinion on Drug Discovery|June 5, 2020
What place does molecular topology have in today's drug discovery?Riccardo Zanni, Maria Galvez-Llompart, Ramon Garcia-Domenech, et al.
Expert Opinion on Drug Discovery|January 8, 2013
Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistaminesJorge Galvez, Maria Galvez-Llompart, Riccardo Zanni, et al.
International Journal of Public Health|August 26, 2015
Measuring the effect of ethnic and non-ethnic discrimination on Europeans' self-rated healthJavier Alvarez-Galvez
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|November 21, 2015
Clinical variability in hereditary optic neuropathies: Two novel mutations in two patients with dominant optic atrophy and Wolfram syndromeAlberto Galvez-Ruiz
Optics Letters|November 28, 2007
Achromatic polarization-preserving beam displacerE J Galvez
Cleveland Clinic Journal of Medicine|July 5, 2012
Tics and Tourette syndrome: an adult perspectiveNestor Galvez-Jimenez
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless DiseaseMaria Galvez-Llompart, Riccardo Zanni, Ramon Garcia-Domenech, et al.
Current Neuropharmacology|December 1, 2017
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?Riccardo Zanni, Ramon Garcia-Domenech, Maria Galvez-Llompart, et al.
Drug Discovery Today. Technologies|January 24, 2014
Molecular topology - dissimilar similaritiesJorge Galvez, Maria Galvez-Llompart, Riccardo Zanni, et al.
Molecular Diversity|March 11, 2015
Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topologyRamon Garcia-Domenech, Riccardo Zanni, Maria Galvez-Llompart, et al.
Pageof 192